IPN goes super Sonic
Tuesday, 16 September, 2008
The proposed acquisition of the Independent Practitioner Network [ASX: IPN] by Sonic Healthcare [ASX: SHL] has been approved by IPN shareholders and will go ahead.
The companies received Federal Court approval to proceed with the merger yesterday.
IPN operates over 90 multidisciplinary medical practices in Australia. Sonic runs a number of pathology labs throughout the world, including Douglass Hanly Moir.
Under the arrangement, IPN shareholders will be given cash payments of $0.27 per share, just over the company's current trading price.
Sonic will take possession of all IPN shares on September 30.
Could 'fusion proteins' reduce errors in a promising gene-editing tool?
Gene-editing tool CRISPR-Cas9 is used, among many things, to engineer new cancer immunotherapies....
Cancer research and clinical trials at the core of new centre
The Australian Cancer Research Foundation Centre for Dynamic Immuno-Oncology (CDIO) has been...
Potential biological targets for vascular dementia
Caused by damage to blood vessels in the brain, there is currently no approved treatment for...
